Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer

DWI has potential to provide a surrogate biomarker of treatment response in advanced cervical cancers. The use of ADC offers an early and reproducible indication of tumour response which may ultimately allow the development of individualised regimens.